S100B induces angiogenesis via the clathrin/FOXO1/β-catenin signaling pathway and contributes to Bevacizumab resistance in epithelial ovarian cancer

血管生成 癌症研究 贝伐单抗 福克斯O1 卵巢癌 信号转导 连环素 上皮性卵巢癌 医学 癌症 细胞生物学 内科学 Wnt信号通路 生物 蛋白激酶B 化疗
作者
Haoya Xu,Wenzhi Li,Huiran Yue,Yang Bai,Jun Li,Xin Lu,Jieyu Wang
出处
期刊:Journal of Advanced Research [Elsevier BV]
卷期号:81: 613-636 被引量:1
标识
DOI:10.1016/j.jare.2025.05.060
摘要

INTRODUCTION: Bevacizumab (BEV), the most common antiangiogenic agent for treating ovarian cancer, prolongs progression-free survival (PFS) but does not significantly improve overall survival (OS). Improving the limited clinical benefit of BEV remains a major challenge in ovarian cancer treatment. Although several studies have explored the mechanisms underlying tumor resistance to BEV, the clinical translation of these findings to overcome BEV resistance has been limited. OBJECTIVES: To identify the key molecules and mechanisms that modulate ovarian cancer sensitivity to BEV. METHODS: RNA sequencing was conducted on BEV-sensitive and BEV-resistant mouse ovarian cancer tissue to identify differentially expressed genes (DEGs). A prognostic assessment was performed and a risk signature was constructed using these DEGs and the BEV-related sequencing datasets. S100B was identified and assessed in angiogenesis using tube formation, 3D fibrin bead sprouting, wound healing, and migration assays. Downstream targets and signaling pathways of S100B in HUVECs were identified by proteomics and validated by western blot. The effect of S100B inhibitors on BEV efficacy was evaluated using in vivo experiments. RESULTS: A BEV-related prognostic signature comprising 11 genes was constructed. Of these, S100B expression significantly increased in BEV-resistant mouse ovarian cancer tissue and significantly correlated with poor PFS and OS of ovarian cancer patients treated with a BEV combination chemotherapy. HUVECs co-cultured with S100B-overexpressing ovarian cancer cells promoted tube formation, sprouting, and migration. Exogenous S100B entered HUVECs via clathrin-mediated endocytosis, downregulated FOXO1 expression, and promoted β-catenin nuclear translocation and transcriptional activity, ultimately enhancing tube formation. The S100B inhibitor pentamidine significantly increased BEV responsiveness and prolonged survival in ovarian tumor-bearing mice. CONCLUSION: S100B is a key molecule regulating ovarian cancer sensitivity to BEV. Paracrine S100B secreted by ovarian cancer cells acts on HUVECs, promoting angiogenesis through the FOXO1/β-catenin pathway. Pentamidine combined with BEV holds potential for overcoming BEV resistance in clinical use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
腼腆的老虎完成签到,获得积分10
1秒前
帅气如蓉完成签到,获得积分10
1秒前
龚正龙完成签到,获得积分10
2秒前
谦让的小馒头完成签到,获得积分10
2秒前
2秒前
babbo完成签到,获得积分10
2秒前
wudizhuzhu233完成签到,获得积分10
2秒前
2秒前
莫华龙完成签到,获得积分10
2秒前
zhuangbaobao发布了新的文献求助10
3秒前
柚屿完成签到,获得积分10
3秒前
自然的哈密瓜完成签到,获得积分10
3秒前
myirwyo完成签到,获得积分10
3秒前
3秒前
Akim的应助被暴躁的碧空采纳,获得10
3秒前
3秒前
杨丽完成签到,获得积分10
3秒前
所所的应助被摆哥采纳,获得10
3秒前
姚美阁完成签到 ,获得积分10
3秒前
等待的大炮完成签到,获得积分10
3秒前
BIXINNNN完成签到 ,获得积分10
3秒前
无尘完成签到 ,获得积分10
4秒前
2mo完成签到,获得积分10
4秒前
tao完成签到 ,获得积分10
4秒前
Pz迷惑完成签到,获得积分10
5秒前
5秒前
dd完成签到,获得积分20
5秒前
NANA完成签到 ,获得积分10
5秒前
5秒前
鞠亚欣发布了新的文献求助10
5秒前
科研通AI6.3的应助被mumu采纳,获得10
6秒前
yinjs158完成签到,获得积分10
6秒前
拉长的远山完成签到,获得积分10
6秒前
义气平蓝发布了新的文献求助10
6秒前
6秒前
wwwwwnnnnn完成签到 ,获得积分10
6秒前
3900发布了新的文献求助10
6秒前
lemon完成签到 ,获得积分10
6秒前
彩色人生完成签到 ,获得积分10
7秒前
Hase发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173580
求助须知:如何正确求助?哪些是违规求助? 9565737
关于积分的说明 21782083
捐赠科研通 7767775
什么是DOI,文献DOI怎么找? 3431604
关于科研通互助平台的介绍 2555855
邀请新用户注册赠送积分活动 2476870